Skip to main content
Top
Published in: World Journal of Pediatrics 8/2023

Open Access 17-11-2022 | Autism Spectrum Disorder | Original Article

Data-driven, client-centric applied behavior analysis treatment-dose optimization improves functional outcomes

Authors: Andrey Ostrovsky, Melissa Willa, Ted Cho, Maxwell Strandberg, Sage Howard, Colin Davitian

Published in: World Journal of Pediatrics | Issue 8/2023

Login to get access

Abstract

Background

With increasing numbers of individuals diagnosed with autism spectrum disorder (ASD) and with affirmation of applied behavior analysis (ABA) as an evidence-based standard of care for ASD, there has been a proliferation of agencies offering ABA services over the last several decades. Disagreement exists among ABA providers and health plans that reimburse those providers on the optimal number of hours of ABA services that should be reimbursed. This study aims to understand whether children who receive more hours of ABA therapy achieve better outcomes and to evaluate the impact of the COVID-19-induced shift to telehealth clinical supervision on outcomes.

Methods

A retrospective cohort analysis was performed using data from the Vineland 3 Comprehensive Interview Form to assess function throughout ABA treatment. Paired sample t tests, independent sample t tests, Cohen’s D, and Pearson correlations were used to determine relationships between Vineland scores and input variables including hours of service and modality of supervision (in-person vs. telehealth).

Results

While statistically and clinically significant improvements in function were observed, children appear to have improved outcomes independent of the number of hours of service received. There were also no significant associations between modality of supervision and Vineland standard scores.

Conclusions

These findings challenge prior research that demonstrated a linear dose–response relationship. By tailoring treatment dosage to the individual client’s needs, providers may be able to better maximize functional progress of the client, to preserve family time, and to utilize health plan dollars more efficiently.
Appendix
Available only for authorised users
Literature
1.
go back to reference Williams JG, Higgins JP, Brayne CE. Systematic review of prevalence studies of autism spectrum disorders. Arch Dis Child. 2006;91:8–15.CrossRefPubMed Williams JG, Higgins JP, Brayne CE. Systematic review of prevalence studies of autism spectrum disorders. Arch Dis Child. 2006;91:8–15.CrossRefPubMed
3.
go back to reference Maenner MJ, Shaw KA, Baio J, Washington A, Patrick M, DiRienzo M, et al. Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 Sites, United States, 2016. MMWR Surveill Summ. 2020;69:1–12.CrossRefPubMedPubMedCentral Maenner MJ, Shaw KA, Baio J, Washington A, Patrick M, DiRienzo M, et al. Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 Sites, United States, 2016. MMWR Surveill Summ. 2020;69:1–12.CrossRefPubMedPubMedCentral
5.
go back to reference Maglione MA, Gans D, Das L, Timbie J, Kasari C. Nonmedical interventions for children with ASD: recommended guidelines and further research needs. Pediatrics. 2012;130:S169–78.CrossRefPubMed Maglione MA, Gans D, Das L, Timbie J, Kasari C. Nonmedical interventions for children with ASD: recommended guidelines and further research needs. Pediatrics. 2012;130:S169–78.CrossRefPubMed
6.
go back to reference Weitlauf AS, McPheeters ML, Peters B, Sathe N, Travis R, Aiello R, et al. Therapies for children with autism spectrum disorder: behavioral interventions update. In: AHRQ comparative effectiveness reviews. Rockville: Agency for Healthcare Research and Quality (US); 2014. p. 137. Weitlauf AS, McPheeters ML, Peters B, Sathe N, Travis R, Aiello R, et al. Therapies for children with autism spectrum disorder: behavioral interventions update. In: AHRQ comparative effectiveness reviews. Rockville: Agency for Healthcare Research and Quality (US); 2014. p. 137.
7.
go back to reference Myers SM, Johnson CP. Management of children with autism spectrum disorders. Pediatrics. 2007;120:1162–82.CrossRefPubMed Myers SM, Johnson CP. Management of children with autism spectrum disorders. Pediatrics. 2007;120:1162–82.CrossRefPubMed
8.
go back to reference Dingfelder HE, Mandell DS. Bridging the research-to-practice gap in autism intervention: an application of diffusion of innovation theory. J Autism Dev Disord. 2011;41:597–609.CrossRefPubMedPubMedCentral Dingfelder HE, Mandell DS. Bridging the research-to-practice gap in autism intervention: an application of diffusion of innovation theory. J Autism Dev Disord. 2011;41:597–609.CrossRefPubMedPubMedCentral
9.
go back to reference Fortune Business Insights. Autism spectrum disorder therapeutics market size, share & COVID-19 impact analysis, by type (autistic disorder, asperger syndrome, pervasive developmental disorder, and others), by treatment type (communication & behavioral therapies {applied behavior analysis (ABA), speech & language therapy} and drug therapies {antipsychotic drugs, selective serotonin reuptake inhibitors, stimulants}), and regional forecast, 2021–2028. In: Market research report. 2021. https://www.fortunebusinessinsights.com/industry-reports/autism-spectrum-disorder-therapeutics-market-101207. Accessed 7 Jan 2022. Fortune Business Insights. Autism spectrum disorder therapeutics market size, share & COVID-19 impact analysis, by type (autistic disorder, asperger syndrome, pervasive developmental disorder, and others), by treatment type (communication & behavioral therapies {applied behavior analysis (ABA), speech & language therapy} and drug therapies {antipsychotic drugs, selective serotonin reuptake inhibitors, stimulants}), and regional forecast, 2021–2028. In: Market research report. 2021. https://​www.​fortunebusinessi​nsights.​com/​industry-reports/​autism-spectrum-disorder-therapeutics-market-101207. Accessed 7 Jan 2022.
10.
go back to reference Peele PB, Lave JR, Kelleher KJ. Exclusions and limitations in children’s behavioral health care coverage. Psychiatr Serv. 2002;53:591–4.CrossRefPubMed Peele PB, Lave JR, Kelleher KJ. Exclusions and limitations in children’s behavioral health care coverage. Psychiatr Serv. 2002;53:591–4.CrossRefPubMed
11.
go back to reference Lord C, McGee JP. Educating children with Autism. Washington, DC: The National Academies Press; 2001. p. 323. Lord C, McGee JP. Educating children with Autism. Washington, DC: The National Academies Press; 2001. p. 323.
12.
go back to reference Peterson KM, Piazza CC, Luczynski KC, Fisher WW. Virtual-care delivery of applied-behavior-analysis services to children with autism spectrum disorder and related conditions. Behav Anal Res and Pract. 2017;17:286–97. Peterson KM, Piazza CC, Luczynski KC, Fisher WW. Virtual-care delivery of applied-behavior-analysis services to children with autism spectrum disorder and related conditions. Behav Anal Res and Pract. 2017;17:286–97.
13.
go back to reference Ferguson J, Craig EA, Dounavi K. Telehealth as a model for providing behaviour analytic interventions to individuals with autism spectrum disorder: a systematic review. J Autism Dev Disord. 2019;49:582–616.CrossRefPubMed Ferguson J, Craig EA, Dounavi K. Telehealth as a model for providing behaviour analytic interventions to individuals with autism spectrum disorder: a systematic review. J Autism Dev Disord. 2019;49:582–616.CrossRefPubMed
14.
go back to reference Linstead E, Dixon DR, French R, Granpeesheh D, Adams H, German R, et al. Intensity and learning outcomes in the treatment of children with autism spectrum disorder. Behav Modif. 2017;41:229–52.CrossRefPubMed Linstead E, Dixon DR, French R, Granpeesheh D, Adams H, German R, et al. Intensity and learning outcomes in the treatment of children with autism spectrum disorder. Behav Modif. 2017;41:229–52.CrossRefPubMed
15.
go back to reference Linstead E, Dixon DR, Hong E, Burns CO, French R, Novack MN, et al. An evaluation of the effects of intensity and duration on outcomes across treatment domains for children with autism spectrum disorder. Transl Psychiatry. 2017;7:e1234.CrossRefPubMedPubMedCentral Linstead E, Dixon DR, Hong E, Burns CO, French R, Novack MN, et al. An evaluation of the effects of intensity and duration on outcomes across treatment domains for children with autism spectrum disorder. Transl Psychiatry. 2017;7:e1234.CrossRefPubMedPubMedCentral
16.
go back to reference Tiura M, Kim J, Detmers D, Baldi H. Predictors of longitudinal ABA treatment outcomes for children with autism: a growth curve analysis. Res Dev Disabil. 2017;70:185–97.CrossRefPubMed Tiura M, Kim J, Detmers D, Baldi H. Predictors of longitudinal ABA treatment outcomes for children with autism: a growth curve analysis. Res Dev Disabil. 2017;70:185–97.CrossRefPubMed
17.
go back to reference Yoder P, Rogers S, Estes A, Warren Z, Munson J, Hellemann G, et al. Interaction of treatment intensity and autism severity on frequency and maturity of spontaneous communication in toddlers with autism spectrum disorder. Autism Res. 2020;13:1902–12.CrossRefPubMed Yoder P, Rogers S, Estes A, Warren Z, Munson J, Hellemann G, et al. Interaction of treatment intensity and autism severity on frequency and maturity of spontaneous communication in toddlers with autism spectrum disorder. Autism Res. 2020;13:1902–12.CrossRefPubMed
18.
go back to reference Rogers SJ, Yoder P, Estes A, Warren Z, McEachin J, Munson J, et al. A multisite randomized controlled trial comparing the effects of intervention intensity and intervention style on outcomes for young children with autism. J Am Acad Child Adolesc Psychiatry. 2021;60:710–22.CrossRefPubMed Rogers SJ, Yoder P, Estes A, Warren Z, McEachin J, Munson J, et al. A multisite randomized controlled trial comparing the effects of intervention intensity and intervention style on outcomes for young children with autism. J Am Acad Child Adolesc Psychiatry. 2021;60:710–22.CrossRefPubMed
19.
go back to reference Patel SY, Mehrotra A, Huskamp HA, Uscher-Pines L, Ganguli I, Barnett ML. Variation in telemedicine use and outpatient care during the COVID-19 pandemic in the United States. Health Aff (Millwood). 2021;40:349–58.CrossRefPubMed Patel SY, Mehrotra A, Huskamp HA, Uscher-Pines L, Ganguli I, Barnett ML. Variation in telemedicine use and outpatient care during the COVID-19 pandemic in the United States. Health Aff (Millwood). 2021;40:349–58.CrossRefPubMed
20.
go back to reference Vismara LA, McCormick C, Young GS, Nadhan A, Monlux K. Preliminary findings of a telehealth approach to parent training in autism. J Autism Dev Disord. 2013;43:2953–69.CrossRefPubMed Vismara LA, McCormick C, Young GS, Nadhan A, Monlux K. Preliminary findings of a telehealth approach to parent training in autism. J Autism Dev Disord. 2013;43:2953–69.CrossRefPubMed
21.
go back to reference Chatham CH, Taylor KI, Charman T, Liogier D’ardhuy X, Eule E, Fedele A, et al. Adaptive behavior in autism: minimal clinically important differences on the Vineland-II. Autism Res. 2018;11:270–83.CrossRefPubMed Chatham CH, Taylor KI, Charman T, Liogier D’ardhuy X, Eule E, Fedele A, et al. Adaptive behavior in autism: minimal clinically important differences on the Vineland-II. Autism Res. 2018;11:270–83.CrossRefPubMed
22.
go back to reference Smith KA, Gehricke J-G, Iadarola S, Wolfe A, Kuhlthau KA. Disparities in service use among children with autism: a systematic review. Pediatrics. 2020;145:S35.CrossRefPubMed Smith KA, Gehricke J-G, Iadarola S, Wolfe A, Kuhlthau KA. Disparities in service use among children with autism: a systematic review. Pediatrics. 2020;145:S35.CrossRefPubMed
23.
go back to reference Sandoval-Norton AH, Shkedy G. How much compliance is too much compliance: is long-term ABA therapy abuse? Cog Psychol. 2019;6:1641258.CrossRef Sandoval-Norton AH, Shkedy G. How much compliance is too much compliance: is long-term ABA therapy abuse? Cog Psychol. 2019;6:1641258.CrossRef
24.
go back to reference Kapp SK, Steward R, Crane L, Elliott D, Elphick C, Pellicano E, et al. ‘People should be allowed to do what they like’: autistic adults’ views and experiences of stimming. Autism. 2019;23:1782–92.CrossRefPubMedPubMedCentral Kapp SK, Steward R, Crane L, Elliott D, Elphick C, Pellicano E, et al. ‘People should be allowed to do what they like’: autistic adults’ views and experiences of stimming. Autism. 2019;23:1782–92.CrossRefPubMedPubMedCentral
25.
go back to reference Schreibman L, Dawson G, Stahmer AC, Landa R, Rogers SJ, McGee GG, et al. Naturalistic developmental behavioral interventions: empirically validated treatments for autism spectrum disorder. J Autism Dev Disord. 2015;45:2411–28.CrossRefPubMedPubMedCentral Schreibman L, Dawson G, Stahmer AC, Landa R, Rogers SJ, McGee GG, et al. Naturalistic developmental behavioral interventions: empirically validated treatments for autism spectrum disorder. J Autism Dev Disord. 2015;45:2411–28.CrossRefPubMedPubMedCentral
Metadata
Title
Data-driven, client-centric applied behavior analysis treatment-dose optimization improves functional outcomes
Authors
Andrey Ostrovsky
Melissa Willa
Ted Cho
Maxwell Strandberg
Sage Howard
Colin Davitian
Publication date
17-11-2022
Publisher
Springer Nature Singapore
Published in
World Journal of Pediatrics / Issue 8/2023
Print ISSN: 1708-8569
Electronic ISSN: 1867-0687
DOI
https://doi.org/10.1007/s12519-022-00643-0

Other articles of this Issue 8/2023

World Journal of Pediatrics 8/2023 Go to the issue